In vivo drug resistance of falciparum malaria in mining areas of Venezuela

Tropical Medicine and International Health

Volumn 7, Issue 9, 2002, Pages 737-743

  Ache A ^a   Escorihuela, M ^b   Vivas, E ^b   Paez E ^b   Miranda, L ^b   Matos, A ^b   Perez W ^b   Diaz O ^b   Izarra, E ^b  

^a Malariología y Saneamiento Ambiental del Estado Bolívar   (Venezuela)

^b Residencias 'La Macareña' ^*  (Venezuela)

Author keywords

Chloroquine; Lot sampling; Plasmodium falciparum; Quinine; Resistant strains; Sulfadoxine pyrimethamine; Treatment failures

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; FANSIDAR; QUININE;

DISEASE CONTROL; DRUG RESISTANCE; MALARIA; MINING; PERFORMANCE ASSESSMENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SCREENING; DRUG SENSITIVITY; FEMALE; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MINING; TREATMENT FAILURE; VENEZUELA;

ADULT; ANIMALS; ANTIMALARIALS; CHLOROQUINE; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; HEALTH PROMOTION; HUMANS; MALARIA, FALCIPARUM; MALE; MINING; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; QUININE; SULFADOXINE; TREATMENT FAILURE; TREATMENT OUTCOME; VENEZUELA;

VENEZUELA;

CINCHONA PUBESCENS; MARIPA; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0036379678     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2002.00936.x     Document Type: Article

References (14)

1. Bruce-Chwatt LJ (1970) Resistance of P. falciparum to chloroquine in Africa: true or false? Transactions of the Royal Society of Tropical Medicine and Hygiene 64 (Special Article), 1-5.
2. Godoy GA, Volcan G, Marenco O et al. (1975) Demostración de resistencia al difosfato de chloroquina por cepas de Plasmodium falciparum infectado naturalmente al hombre en un área del estado, Bolívar, Venezuela. Revista do Instituto de Medicina Tropical de São Paulo 17, 38-48.
3. Godoy GA, Volcan GS, Guevara R et al. (1977) Venezuelan strains of Plasmodium falciparum resistant to sulfa and pyrimethamine as demonstrated by in vitro test. Revista Latinoamericana de Microbiología 19, 229-231.
4. Lemeshow S & Taber S (1991) Lot quality assurance sampling: single- and double-sampling plans. World Health Statistics Quarterly 44, 115-132.
5. Lévy-Lambert E (1974) Basic Techniques for a Medical Laboratory. WHO, Geneva.
6. Maberti S (1960) Desarrollo de resistencia a la Pirimetamina. Presentación de 15 casos estudiados en Trujillo. Archivos Venezolanos de Medicina Tropical y Parasitología Médica III, 239-259.
7. Magris M & Riggione F (1994) Susceptibilidad del Plasmodium falciparum 'in vitro' a la cloroquina, amodiaquina, quinina y pirimetamina-sulfadoxina en el estado Amazonas, Venezuela. Acta Científica Venezolana 45 (Suplemento 1), 250.
8. Maynadie M, Peceño C, Noriega PL & Yarzabal L (1989) Susceptibility of Plasmodium falciparum strains to chloroquine and mefloquine in the Amazonas Federal Territory of Venezuela. Transactions of the Royal Society of Tropical Medicine and Hygiene 83, 586-588.
9. Organización Mundial de la Salud/Organización Panamericana de la Salud (1998) Evaluación de la eficacia terapéutica de los medicamentos para el tratamiento del paludismo por Plasmodium falciparum sin complicaciones en las Américas. OMS/OPS/HCP/113/98 (Spanish), WHO/PAHO 113/98, 2-34.
10. Peters W (1970) Drug resistance in human malarias - III. Resistance to 4-aminoquinolines and multiple drug resistance in P. falciparum. In: Chemotherapy and Drug Resistance in MALARIA. (ed.) Academic Press, London.
11. Stott GJ & Lewis SM (1995) A simple and reliable method for estimating haemoglobin. Bulletin of the World Health Organization 73, 369-373.
12. World Health Organization (1991) Basic Malaria Microscopy, Part I and II. WHO, Geneva.
13. World Health Organization (1995) Guidelines for Good Clinical Practice for Trials on Pharmaceutical Products. WHO Technical Report Series no. 850, WHO, Geneva.
14. World Health Organization (1996) Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. WHO/MAL/96.1077. WHO, Geneva.